|
 |
On
the 22nd of March 2007 VASTox plc, a leading UK biotechnology company
acquired the zebrafish drug discovery company DanioLabs Ltd for
£15 million. VASTox are an innovative drug discovery company
which has a broad set of clinical, pre-clinical and discovery programmes
across a range of serious disease areas with high unmet medical
need. VASTox’s drug discovery programmes are supported by
the company’s world leading technology platforms in zebrafish
chemical genomics and carbohydrate chemistry.
The scientific expertise and capabilities of DanioLabs in zebrafish biology provide a synergistic fit with VASTox’s technologies and the enlarged company will be the global force in the use of this innovative drug discovery and development platform. For
further information about VASTox, please follow this link to the
Company’s website: www.vastox.com |
|
